8/6/2019 Pharma Trends

http://slidepdf.com/reader/full/pharma-trends 1/1

Market Research Reports 

Get Daily Research Reports. Weekly Market Roundup, Stock Tips & Ideas! :  AngelBroking.com/ResearchReports 

The global pharmaceutical market research has been done by many companies and

almost all of the market reports indicate a significant growth of of pharma market in

2010. The forecasting indicates pharmaceutical market growth of about 4 - 6% in

2010.

Pharmaceutical Industry Trends- Global Scenario

If present industry overview is taken into consideration then the global

pharmaceutical market in 2010 is projected to grow 4 - 6% exceeding $825 billion.

The global pharmaceutical market sales is expected to grow at a 4 - 7% compound

annual growthrate (CAGR) through 2013. This industry growth is driven by stronger 

near-term growth in the US market and is based on the global macroeconomy, the

changing combination of innovative and mature products apart from the rising

influence of healthcare access and funding on market demand. Global

pharmaceutical market value is expected to expand to $975+ billion by 2013. Different regions of the world will

influence the pharmaceutical industry trends in different ways.

Asia Pacific Pharmaceutical Market

The pharma market world over will experience significant shifts. Asia-Pacific region will emerge as the fastest growingpharmaceutical market over the recent past. The reason for this positive shift can be attributed to the low costs and

favorable regulatory environment. This region has experienced important developments regarding contract

manufacturing, especially in generics and APIs. Increased R&D activities in the region has helped Asia-Pacific

pharmaceutical industry to achieve an estimated market size of around US$ 187 Billion in 2009. Here, the

pharmaceutical industry is expected to grow at a CAGR of around 12.6% during 2010-2012. It can, in fact, become

the global API production hub in next few years.

pharmaceutical sales are growing at a fast rate in India, China, Malaysia, South Korea and Indonesia due to the rising

disposable income, several health insurance schemes (that ensures the sales of branded drugs), and intense

competition among top pharmaceutical companies in the region (that has boosted the availability of low cost drugs).

China¶s pharmaceutical market will continue to grow at a 20+ % annually, and will contribute 21% of overall global

growth through 2013. India - 3rd Largest Producer of Pharmaceuticals Across the World- is already a US$ 8.2 Billionpharmaceutical market. The Indianpharmaceutical industry is further expected to grow by 10% in the year 2010.

Middle East Pharmaceutical Market

The Middle East combined with the African Pharmaceutical market is projected to grow at a CAGR of around 11%

during 2010-2012. The development of infrastructure and rapidly changing regulations in this region are being seen

as the cause of its growth. Also there is a high prevalence of diseases and huge population base that increases the

overall pharmaceutical sales in this part of the world. Presently South Africa, Saudi Arabia and Israel dominate the

region's pharmaceutical industry due to their better infrastructure and regulatory environment. However, The Middle

East pharma market depends on importedpharmaceutical drugs and therapeutics. The governments of countries in

this region are taking measures to raise their domestic production through heavy investments in the pharmaceutical

industry. How far they are successful in the attempt of becoming considerable pharma production center remains to

be seen.

Pharmaceutical Drugs Trends

  Anti-Diabetic Drugs and those for cardiovascular diseases are expected to see the fastest growth in 2011.

Cardiovascular patients will increase to 251 million in 2010, with the greatest rate of growth forecast for the US

market. This is due to the changes in demographics and lifestyle that will boost the cardiovascular sales. However,

the growth rates will be limited by continued patent expiries for major products and due to the lack of of novel

therapies. The anti-hypertensives drugs will dominate the global cardiovascular market with a market share of nearly

50%.